Liu, Xia

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

Yang, G., Buhrlage, S. J., Tan, L., Liu, X., Chen, J., Xu, L., Tsakmaklis, N., Chen, J. G., Patterson, C. J., Brown, J. R., et al. (2016) · Blood

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 135

Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections

Li, X., Liu, X., Tian, L., & Chen, Y. (2016) · Clinical Reviews in Allergy & Immunology

Hepatitis B Virus StudiesHepatitis C virus research

Cited by 104

Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis

Gui, H., Liu, X., Wang, Z.-W., He, D.-Y., Su, D.-F., & Dai, S.-M. (2014) · Rheumatology

Rheumatoid Arthritis Research and TherapiesCannabis and Cannabinoid Research

Cited by 76